Literature DB >> 12904469

Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation.

Markus Schubert1, Derek P Brazil, Deborah J Burks, Jake A Kushner, Jing Ye, Carrie L Flint, Janet Farhang-Fallah, Pieter Dikkes, Xavier M Warot, Carlos Rio, Gabriel Corfas, Morris F White.   

Abstract

Insulin resistance and diabetes might promote neurodegenerative disease, but a molecular link between these disorders is unknown. Many factors are responsible for brain growth, patterning, and survival, including the insulin-insulin-like growth factor (IGF)-signaling cascades that are mediated by tyrosine phosphorylation of insulin receptor substrate (IRS) proteins. Irs2 signaling mediates peripheral insulin action and pancreatic beta-cell function, and its failure causes diabetes in mice. In this study, we reveal two important roles for Irs2 signaling in the mouse brain. First, disruption of the Irs2 gene reduced neuronal proliferation during development by 50%, which dissociated brain growth from Irs1-dependent body growth. Second, neurofibrillary tangles containing phosphorylated tau accumulated in the hippocampus of old Irs2 knock-out mice, suggesting that Irs2 signaling is neuroprotective. Thus, dysregulation of the Irs2 branch of the insulin-Igf-signaling cascade reveals a molecular link between diabetes and neurodegenerative disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12904469      PMCID: PMC6740672     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  168 in total

Review 1.  Role of insulin resistance in Alzheimer's disease.

Authors:  Zhiyou Cai; Ming Xiao; Liying Chang; Liang-Jun Yan
Journal:  Metab Brain Dis       Date:  2014-11-16       Impact factor: 3.584

2.  Insulin receptor substrate 2 (IRS2)-deficient mice show sensorineural hearing loss that is delayed by concomitant protein tyrosine phosphatase 1B (PTP1B) loss of function.

Authors:  Silvia Murillo-Cuesta; Guadalupe Camarero; Agueda González-Rodríguez; Lourdes Rodríguez De La Rosa; Deborah J Burks; Carlos Avendaño; Angela M Valverde; Isabel Varela-Nieto
Journal:  Mol Med       Date:  2012-03-30       Impact factor: 6.354

3.  Role for neuronal insulin resistance in neurodegenerative diseases.

Authors:  Markus Schubert; Dinesh Gautam; David Surjo; Kojihiko Ueki; Stephanie Baudler; Dominic Schubert; Tatsuya Kondo; Jens Alber; Norbert Galldiks; Eckehardt Küstermann; Saskia Arndt; Andreas H Jacobs; Wilhelm Krone; C Ronald Kahn; Jens C Brüning
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-23       Impact factor: 11.205

Review 4.  Neurodevelopmental effects of insulin-like growth factor signaling.

Authors:  John O'Kusky; Ping Ye
Journal:  Front Neuroendocrinol       Date:  2012-06-16       Impact factor: 8.606

Review 5.  Metabolic Alterations Associated to Brain Dysfunction in Diabetes.

Authors:  João M N Duarte
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

6.  Curcumin ameliorates impaired insulin/IGF signalling and memory deficit in a streptozotocin-treated rat model.

Authors:  Ahmet Turan Isik; Turgay Celik; Gokhan Ulusoy; Onder Ongoru; Birsen Elibol; Huseyin Doruk; Ergun Bozoglu; Hakan Kayir; Mehmet Refik Mas; Serif Akman
Journal:  Age (Dordr)       Date:  2008-10-08

Review 7.  Intranasal insulin therapy for cognitive impairment and neurodegeneration: current state of the art.

Authors:  Suzanne M de la Monte
Journal:  Expert Opin Drug Deliv       Date:  2013-11-12       Impact factor: 6.648

8.  Insulin receptor substrate 2-mediated phosphatidylinositol 3-kinase signaling selectively inhibits glycogen synthase kinase 3β to regulate aerobic glycolysis.

Authors:  Justine Landis; Leslie M Shaw
Journal:  J Biol Chem       Date:  2014-05-08       Impact factor: 5.157

Review 9.  Brain hypometabolism triggers PHF-like phosphorylation of tau, a major hallmark of Alzheimer's disease pathology.

Authors:  Thomas Arendt; Jens Stieler; Max Holzer
Journal:  J Neural Transm (Vienna)       Date:  2014-12-06       Impact factor: 3.575

10.  Early life nutrient restriction impairs blood-brain metabolic profile and neurobehavior predisposing to Alzheimer's disease with aging.

Authors:  Masatoshi Tomi; Yuanzi Zhao; Shanthie Thamotharan; Bo-Chul Shin; Sherin U Devaskar
Journal:  Brain Res       Date:  2012-12-07       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.